European Journal of Rheumatology · 2020 · 22 citations · 44 references
MedicineDermatologyDermatologic SurgeryDermatopathologyOphthalmic SurgeryNeurocutaneous SyndromesScleral DisordersDiagnostic ReportsEn Coup De SabreLinear SclerodermaOphthalmologic FindingsOphthalmologic ManifestationsParry-romberg SyndromeScleroderma Treatment
To provide an update on the current management, including evaluation and treatment, and the available diagnostic tools for linear scleroderma of the head, i.e., Parry-Romberg Syndrome and en coup de sabre (PRS/ECDS). A rapid scoping review of the literature was conducted to include manuscripts published in English between 2010 and 2019. Literature searches were performed in PubMed and EMBASE databases. The were analyzed for descriptive statistic reporting. This study reviewed 215 manuscripts reporting these 1430 patients. Surgical reports comprised the majority of the reviewed literature. Most PRS/ECDS did not appear to receive comprehensive multisubspecialty evaluation for extracutaneous manifestations; 21% of cases noted neurological screening, 4% noted dental screening, and 3% noted ophthalmologic screening. Methotrexate and glucocorticoids remain the most frequent choice for immunosuppressive treatment, though fewer than 7% of patients reported receiving systemic medical therapies. Surgical procedures for cosmetic or functional improvement were common (59%) among the reported patients. Autologous fat grafting was the most frequently utilized cosmetic treatment (50% of procedures) followed by free flap transfers (24% of procedures). There is ongoing need for standardized evaluation, monitoring, and treatment to prevent morbidity in PRS/ECDS, especially in children. When these patients are managed by rheumatologists, methotrexate, and steroids remain the first-line treatment, but a review of the published literature reflects that this may be a minority. Most PRS/ECDS patients are not evaluated in a multidisciplinary fashion. We propose comprehensive evaluations across subspecialties at the baseline and follow-up levels to monitor disease activity and record extracutaneous manifestations, treatment algorithms, and surgical intervention considerations.
44
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher, A. Liberati, Jennifer Tetzlaff et al. · BMJ · 2009 · 83.3K citations · Full text
Suzanne C. Li, Kathryn S. Torok, Elena Pope et al. · Arthritis Care & Research · 2012 · 211 citations · Full text
Medicine, Dermatology, Pediatrics +14
Thaschawee Arkachaisri, Soamarat Vilaiyuk, Suzanne C. Li et al. · The Journal of Rheumatology · 2009 · 181 citations · Full text
Kyung S. Koh, Tae Suk Oh, Hoon Kim et al. · Annals of Plastic Surgery · 2012 · 168 citations
Medicine, Plastic Surgery, Surgery +17